Full metadata record
DC FieldValueLanguage
dc.contributor.authorLin, Chia-Tungen_US
dc.contributor.authorKuo, Shao-Hsuanen_US
dc.contributor.authorLin, Pei-Hengen_US
dc.contributor.authorChiang, Pei-Huanen_US
dc.contributor.authorLin, Wan-Hsuanen_US
dc.contributor.authorChang, Chun-Haoen_US
dc.contributor.authorTsou, Ping-Hsienen_US
dc.contributor.authorLi, Bor-Ranen_US
dc.date.accessioned2020-07-01T05:21:17Z-
dc.date.available2020-07-01T05:21:17Z-
dc.date.issued2020-08-01en_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.snb.2020.128003en_US
dc.identifier.urihttp://hdl.handle.net/11536/154366-
dc.description.abstractExtreme point-of-care testing (POCT) is a medical test performed at or near patients at a resource-limited condition. POCT technology has advantages over traditional medical lab tests for molecular detection and infection diagnosis, such as being simple, portable, low-cost, and user-friendly. However, some POCT devices might rely on bulky equipment, and some might be easily influenced by components in biofluid, which might result in higher prices and lower accuracy. In this paper, we demonstrated a low-cost method for detecting bacterial infection in the early stage. We designed a hand-powered centrifugal microfluidic (CMF) disc with magnetic chitosan beads (MCBs) to detect specific circulating antibodies in human whole blood. Nine identical units was used for calibration curve plotting and sample testing. The MCBs, generated with another microfluidic chip and coated with MBL proteins (biomarker of drug-resistant Streptococcus pneumoniae, DRSP, taken as an example for bacterial infection), were served as the substrate of sandwich-structured enzyme-linked immunosorbent assays (ELISA) and as the micro stirring sphere at the same time. The limit of detection (LOD) in PBS and human whole blood were 22.67 ng/mL and 24.83 ng/mL, respectively. The comparison between calibration curves from the antibody spiked in human whole blood and that in PBS was shown to prove the high compatibility and low interference of biofluid, and the recovery rate was 92 %. In conclusion, since our low-cost, time-saving, and user-friendly hand-powered CMF device with minimally consumed electricity detected the target antibody precisely, we believe that other similar assays would be feasible as well. Therefore, we are firmly convinced that this alternative POCT device may lead to the development of next-generation healthcare diagnoses.en_US
dc.language.isoen_USen_US
dc.subjectPoint-of-careen_US
dc.subjectELISAen_US
dc.subjectCentrifugal microfluidicen_US
dc.subjectStreptococcus pneumoniaeen_US
dc.subjectWhole blooden_US
dc.subjectMagnetic chitosan beadsen_US
dc.titleHand-powered centrifugal microfluidic disc with magnetic chitosan bead-based ELISA for antibody quantitationen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.snb.2020.128003en_US
dc.identifier.journalSENSORS AND ACTUATORS B-CHEMICALen_US
dc.citation.volume316en_US
dc.citation.spage0en_US
dc.citation.epage0en_US
dc.contributor.department交大名義發表zh_TW
dc.contributor.department生醫工程研究所zh_TW
dc.contributor.departmentNational Chiao Tung Universityen_US
dc.contributor.departmentInstitute of Biomedical Engineeringen_US
dc.identifier.wosnumberWOS:000533548900003en_US
dc.citation.woscount0en_US
Appears in Collections:Articles